Benzz 180 Mg Injection

Description

About Benzz 180 mg Injection

Benzz 180 mg Injection contains 180 mg of bendamustine per vial, supplied as a single vial. Bendamustine is a cytotoxic chemotherapy medicine of the alkylating agent class. Treatment is prescribed and supervised by a cancer specialist. It is given as an infusion by a doctor or nurse in a treatment centre, never self-administered.

How it works

Bendamustine attaches chemically to the DNA inside dividing cells and links its strands together, so the damage cannot be repaired and the cell dies. It combines features of a nitrogen mustard and of a purine analogue, which is why its pattern of activity differs from other alkylating agents.

What it is used for

Bendamustine is used in chronic lymphocytic leukaemia and in indolent non-Hodgkin lymphoma, including disease that has progressed after other treatment.

Important: what this medicine is not

Bendamustine is not an anti-inflammatory medicine and has no role in arthritis or joint pain.

Safety and monitoring

It lowers blood counts, so infection, bruising and bleeding are the main risks and blood is checked before each cycle – report fever, sore throat, unusual bruising or breathlessness at once. Reactions during or soon after the infusion can occur. Where a large amount of cancer is present, rapid breakdown of cells can upset the blood chemistry in the first days of treatment, which the team will monitor and prevent. Serious skin reactions have been reported; report any widespread rash.

Prescription and storage

A prescription from your healthcare provider is required to purchase bendamustine. Storage and handling follow the pack instructions and are managed by the treating centre.